Laddy DJ, Yan J, Khan AS, Anderson H, Cohn A, Gree. Electroporation of Synthetic DNA Antigens Offers Protection in Non-Human Primates Challenged with Highly Pathogenic Avian Influenza. J Virol. 2009 Feb 11.
Avian influenza highlights the need for novel vaccination techniques that would allow for the rapid design and production of safe and effective vaccines. An ideal platform would be capable of inducing both protective antibodies and potent cellular immune responses. These potential advantages of DNA vaccines remain unrealized due to a lack of efficacy in large animal studies and in human trials. Questions remain regarding the potential utility of cellular immune responses against influenza in primates. In this report we demonstrate that by construct optimization and in vivo electroporation of synthetic DNA-encoded antigens we observe induction of cross-reactive cellular and humoral immune responses individually capable of providing protection from influenza infection in the rhesus macaque. These studies advance both the DNA vaccines field as well as providing a novel more tolerable vaccine with broad immunogenicity to avian influenza. This approach appears important for further investigation including studies in humans.
See Also:
Latest articles in those days:
- Structures of H5N1 influenza polymerase with ANP32B reveal mechanisms of genome replication and host adaptation 2 days ago
- Risk assessment of a highly pathogenic H5N1 influenza virus from mink 2 days ago
- Detection of clade 2.3.4.4b highly pathogenic H5N1 influenza virus in New York City 2 days ago
- Sequence-based epitope mapping of high pathogenicity avian influenza H5 clade 2.3.4.4b in Latin America 3 days ago
- Guanylate-binding protein 1 inhibits inflammatory factors produced by H5N1 virus through Its GTPase activity 3 days ago
[Go Top] [Close Window]